• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The rationale for use of topical corticosteroids in allergic rhinitis.

作者信息

Mygind N, Dahl R

机构信息

Department of Otorhinolaryngology, Rigshospitalet, Copenhagen, Denmark.

出版信息

Clin Exp Allergy. 1996 May;26 Suppl 3:2-10. doi: 10.1111/j.1365-2222.1996.tb00652.x.

DOI:10.1111/j.1365-2222.1996.tb00652.x
PMID:8735852
Abstract

The rationale for using topical corticosteroids in the treatment of allergic rhinitis is that high drug concentrations can be achieved at receptor sites in the nasal mucosa, with minimal risk of systemic adverse effects. Topical corticosteroids have been demonstrated to reduce the number of Langerhans' cells (or their markers) in the nasal mucosa, and this is thought to attenuate antigen presentation. T lymphocytes have been identified as being significant in orchestrating the immune-inflammatory response, particularly the TH2 cells, which represent an important target for topical corticosteroids. TH2 cell-evoked mast cells and basophils are the sole producers of histamine, a mediator of major importance for rhinitis symptoms. Several studies have shown that the increased number of mast cells and basophils in the epithelium following antigen challenge/exposure, are markedly reduced by topical corticosteroids. Furthermore, the number of eosinophils, an important morphological marker of allergic rhinitis, can be profoundly reduced by treatment with topical corticosteroids. The rationale for topical treatment is strengthened by evidence of inhibition of cytokine release from surface epithelial cells, resulting in reduced recruitment and activation of mast cells, basophils, and eosinophils, which may be attributed to the high drug concentration achieved in epithelial cells. Ongoing inflammation in the mucous membrane is indicated by entry of plasma into the nasal lumen which subsides with the anti-inflammatory efficacy of topical corticosteroids. In contrast to antihistamine therapy, which has little effect on nasal blockage, pretreatment with topical corticosteroids results in almost complete attenuation of late-phase symptoms including nasal blockage, and moderate efficacy in early phase symptoms. Clearly, the spectrum of anti-inflammatory activity afforded by topical corticosteroid therapy is of clinical significance in reducing the three major symptoms of allergic rhinitis- sneezing, watery rhinorrhoea and nasal blockage.

摘要

相似文献

1
The rationale for use of topical corticosteroids in allergic rhinitis.
Clin Exp Allergy. 1996 May;26 Suppl 3:2-10. doi: 10.1111/j.1365-2222.1996.tb00652.x.
2
Mode of action of intranasal corticosteroids.鼻内用糖皮质激素的作用方式。
J Allergy Clin Immunol. 2001 Jul;108(1 Suppl):S16-25. doi: 10.1067/mai.2001.115561.
3
Intranasal corticosteroids for allergic rhinitis.用于过敏性鼻炎的鼻内用皮质类固醇
Pharmacotherapy. 2002 Nov;22(11):1458-67. doi: 10.1592/phco.22.16.1458.33692.
4
The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids.局部用皮质类固醇治疗常年性变应性鼻炎和非变应性鼻炎的药理学基础。
Allergy. 1997;52(36 Suppl):33-40. doi: 10.1111/j.1398-9995.1997.tb04820.x.
5
Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.鼻内用抗组胺药和鼻内用皮质类固醇治疗变应性鼻炎的安全性和耐受性概况。
Drug Saf. 2003;26(12):863-93. doi: 10.2165/00002018-200326120-00003.
6
Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapy.
Allergy. 1997;52(36 Suppl):29-32. doi: 10.1111/j.1398-9995.1997.tb04819.x.
7
The inflammatory nature of allergic disease.过敏性疾病的炎症本质。
Clin Exp Allergy. 1998 Dec;28 Suppl 6:20-4. doi: 10.1046/j.1365-2222.1998.0280s6020.x.
8
Effect of corticosteroids on nasal blockage in rhinitis measured by objective methods.采用客观方法测量皮质类固醇对鼻炎患者鼻阻塞的影响。
Allergy. 1997;52(40 Suppl):39-44. doi: 10.1111/j.1398-9995.1997.tb04883.x.
9
Management of allergic rhinitis: focus on intranasal agents.过敏性鼻炎的管理:聚焦于鼻内用药
Pharmacotherapy. 1989;9(6):338-50. doi: 10.1002/j.1875-9114.1989.tb04148.x.
10
Allergic rhinitis: not purely a histamine-related disease.变应性鼻炎:并非单纯的组胺相关疾病。
Allergy. 2000;55 Suppl 64:7-16. doi: 10.1034/j.1398-9995.2000.00802.x.

引用本文的文献

1
Topical Formulations Based on Ursolic Acid-Loaded Nanoemulgel with Potential Application in Treatment.基于负载熊果酸的纳米乳凝胶的局部制剂及其在治疗中的潜在应用
Pharmaceutics. 2023 Oct 31;15(11):2559. doi: 10.3390/pharmaceutics15112559.
2
Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis.评估特发性声门下狭窄的多次腔内类固醇注射后的副作用。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):445-450. doi: 10.1007/s00405-020-06371-3. Epub 2020 Sep 18.
3
Mechanisms of action of topical corticosteroids in psoriasis.
外用皮质类固醇治疗银屑病的作用机制。
Int J Endocrinol. 2012;2012:561018. doi: 10.1155/2012/561018. Epub 2012 Nov 5.
4
The role of inhaled and/or nasal corticosteroids on the bronchodilator response.吸入性和/或鼻用皮质类固醇对支气管扩张剂反应的作用。
Korean J Pediatr. 2010 Nov;53(11):951-6. doi: 10.3345/kjp.2010.53.11.951. Epub 2010 Nov 30.
5
Mometasone furoate. A review of its intranasal use in allergic rhinitis.糠酸莫米松。关于其在变应性鼻炎中鼻内使用的综述。
Drugs. 1998 Oct;56(4):725-45. doi: 10.2165/00003495-199856040-00018.